Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03038165
Other study ID # GMC170114CTIL
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 2016
Est. completion date December 2017

Study information

Verified date June 2019
Source Western Galilee Hospital-Nahariya
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

While the exact pathogenesis of Intradialytic hypertension remains to be determined, several mechanisms were proposed to be involved. The main factors to determine the arterial blood pressure are the peripheral vascular resistance and cardiac output. The assumption is that the increase of blood pressure is related to the increase in peripheral vascular resistance during the dialysis session, due to fluid removal and fast reduction of the intravascular volume reduction.

Using the NICAS device (Non-Invasive Cardiac System), the hemodynamic profile in patients with intradialytic hypertension will be evaluated


Description:

The number of patients with end stage renal disease (ESRD) is growing worldwide and nowadays hemodialysis (HD) treatment is the prevalent modality of renal replacement therapy. Paradoxically an increase of BP during or immediately after the HD sessions has been observed in some patients. This phenomenon is referred to as Intradialytic Hypertension (IDH). The focus will be on systolic BP increase ≥ 10 mmHg during or immediately after hemodialysis which results in post-dialysis hypertension BP above ≥130/80 mmHg. IDH affects up to 10-15% of hemodialysis patients. Patients with IDH have unfavorable outcomes; previous epidemiological data showed that IDH is associated with higher cardiovascular morbidity and mortality rates.

From the view of hemodynamic profile, peripheral resistance and cardiac output are the most important factors contributing to arterial blood pressure. The pathogenesis of IDH is likely to be multifactorial. Several mechanisms were proposed to be involved in the pathogenesis of this phenomenon.

Endothelial dysfunction, increased activity of the renin angiotensin aldosterone system (RAAS) and activation of the sympathetic nervous system had been shown to be involved in the increase of blood pressure during Hemodialysis in this group of patients.

None of these possible explanations or their inter-relationships has been studied in a controlled experimental setting and the actual physiological changes during hemodialysis in intradialytic hypertensive patients still remain unexplored.

The NICAS (Non-Invasive Cardiac System) device, used mainly for noninvasive cardiac diagnostic purposes, is substantially equivalent to the use of other hemodynamic evaluation tools, yet it is non-invasive and provides on-line data regarding the hemodynamic status of patients. Using this device, the hemodynamic changes during the HD session of IDH patients will be investigated.

By using the NICAS device, the hemodynamics parameters changes during the dialysis session will be measured. The parameters that will be measured are heart rate, stroke volume, cardiac index, cardiac power index and total peripheral vascular resistance.

During the hemodialysis treatment several hemodynamic changes may occur due to intravascular volume reduction. Changes in peripheral vascular resistance, cardiac output and cardiac power index contribute to the hemodynamic stability during the dialysis session.

By using a non-invasive technique, the NICAS device,hemodynamic changes that occur during the hemodialysis session will be evaluated.

An increase of blood pressure is correlated with the increase of peripheral vascular resistance and/or the increase of cardiac output, reflecting an adjustment to the fast changes in the intravascular volume.

Aim of the study The hemodynamic changes that occur during the dialysis session in patients with intradialytic hypertension by using the NICAS device will be evaluated.

Methods This will be an observational prospective study that examines hemodynamic parameters before and immediately after the dialysis session.

The hemodynamic data is collected by the investigators during the study period. These parameters will be obtained before starting the dialysis session, every hour during the dialysis session and at the end of it.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Intradialytic hypertension at least once weakly

- Age older than 18 years

- Chronic hemodialysis treatment more than 3 months

- Stable dialysis treatment conditions

- Stable antihypertensive treatment for the last 4 weeks prior the study

- Patients able and agree to sign the consent form.

Exclusion Criteria:

- Recent changes in the antihypertensive treatment

- Recent acute cardiovascular event

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Western Galilee Hospital Nahariya

Sponsors (1)

Lead Sponsor Collaborator
Western Galilee Hospital-Nahariya

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peripheral vascular resistance (dyne/sec/cm5) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
Primary Stroke volume (ml) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
Primary Stroke index (ml/m2) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
Primary Cardiac output (l/min) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
Primary Cardiac index (l/min/m2) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
Primary Heart rate (bpm) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
Primary blood pressure (mm/Hg) In patients with intradialytic hypertension During 3 consecutive hemodialysis session in one week
See also
  Status Clinical Trial Phase
Completed NCT01371890 - Mechanisms and Treatment of Intradialytic Hypertension - Sodium
Completed NCT00827775 - Mechanisms and Treatment of Intradialytic Hypertension Phase 4
Completed NCT05430438 - Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension N/A
Completed NCT01862497 - Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
Completed NCT01916668 - A Cross-sectional Study on Intradialytic Hypertension at Four Haemodialysis Units in the Western Cape N/A